The president of Russia, Vladimir Putin, received the Russian nasal vaccine against the Coronavirus as part of the trials carried out by the Gamaleya Center, creator of the Sputnik V drug, as reported on Wednesday.
At a meeting with members of the Russian cabinet, the head of the Kremlin recalled that last Sunday he reacted against the Coronavirus with the Russian Drug Russian drug Sputnik Light.
The next day, Putin said, the nasal form of the vaccine was administered, which at the moment is in the testing phase.
The Russian president had previously expressed his desire to participate in the trials of nasal drug, on whose development Russia informed last summer.
Putin was vaccinated in February against Coronavirus, but only revealed in June that the Sputnik V vaccine had been inoculated, which is authorized in 71 countries so far and has an effectiveness of 97.6%, although it is not yet approved by the World Organization of health (WHO) nor by the European Medicines Agency (EMA).
The head of the Kremlin today insisted on the need for vaccination and revaccination against Coronavirus, while it was against the obligation of the procedure and emphasized the importance of awareness campaigns.
The Russian Deputy Prime Minister, Tatiana Golikova, today placed collective immunity against Coronavirus in Russia by 50.4% and overtaken that throughout the day the country would record its first vaccine for children between 12 and 17 years old.
In an attempt to raise awareness about the need of the vaccine, the doctors of the main Russian hospitals today disseminated an open letter in which they invited some acquaintances of immunization to visit the intensive care units of hospitals to see their own Eyes the situation caused by the disease.
Russia registered in the last 24 hours 33,558 new cases of Coronavirus and 1,240 deaths by the infection.Updated Date: 25 November 2021, 09:34